Doxorubicin-Teva 200 mg/100 ml, Injektionslösung
7680593500045
CH-59350
L01DB01
07.16.1.
1 / 3
google
Details
- Product number
- 5935004
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- doxorubicini hydrochloridum 200 mg, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 100 ml, natrium 355.16 mg.
Articles (1)
Doxorubicin-Teva 200 mg/100 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
355.16 MG | Substance | HBESI |
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 59350
- Drug name
- Doxorubicin-Teva, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01DB01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 02/12/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DOXORUBICIN Teva 200 mg/100ml flac 100 ml
- Description (DE)
- DOXORUBICIN Teva 200 mg/100ml Durchstf 100 ml
- Narcotic (BTM)
- No
Available generics
Doxorubicin Accord liposomal, Konzentrat zur Herstellung einer Infusionsdispersion
GTIN:
7680689610016
CHF 180.45
Doxorubicin Accord liposomal, Konzentrat zur Herstellung einer Infusionsdispersion
GTIN:
7680689610023
CHF 339.90
Doxorubicin Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680548280015
CHF 28.50
Doxorubicin Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680548280022
CHF 76.55
Doxorubicin Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680548280039
CHF 136.70